MARAVAI LIFESCIENCES HLDGS-A (MRVI)
US56600D1072 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to MRVI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.35. This target is 14.61% above the current price.
MRVI was analyzed by 18 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about MRVI.
In the previous month the buy percentage consensus was at a similar level.
MRVI was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-10 | Craig-Hallum | Initiate | Buy |
| 2024-02-23 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-23 | Stifel | Maintains | Buy -> Buy |
| 2023-12-12 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-11-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-11-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-08 | Deutsche Bank | Maintains | Buy -> Buy |
| 2023-08-08 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2023-08-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-08-08 | Baird | Maintains | Outperform -> Outperform |
| 2023-08-08 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-08-08 | Credit Suisse | Maintains | Neutral -> Neutral |
| 2023-05-23 | Credit Suisse | Downgrade | Outperform -> Neutral |
| 2023-05-10 | Goldman Sachs | Maintains | Neutral |
| 2023-05-10 | Morgan Stanley | Maintains | Overweight |
| 2023-05-09 | Deutsche Bank | Maintains | Buy |
| 2023-05-09 | RBC Capital | Maintains | Outperform |
| 2023-05-09 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2023-05-09 | Credit Suisse | Maintains | Outperform |
| 2023-02-24 | Morgan Stanley | Maintains | Overweight |
| 2023-02-23 | Keybanc | Maintains | Overweight |
| 2023-02-23 | Baird | Maintains | Outperform |
| 2023-02-23 | Credit Suisse | Maintains | Outperform |
| 2023-01-17 | Goldman Sachs | Maintains | Buy |
| 2023-01-05 | UBS | Downgrade | Buy -> Neutral |
| 2022-12-14 | Deutsche Bank | Initiate | Buy |
| 2022-12-07 | RBC Capital | Initiate | Outperform |
| 2022-11-04 | Goldman Sachs | Maintains | Buy |
| 2022-11-04 | Morgan Stanley | Maintains | Overweight |